Clinical Trials in New York

Showing 4541-4560 of 22,668 trials

Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant

NCT06938867

This is a Phase 1b/2a study in allogenic hematopoietic stem cell transplant patients to investigate the safety, PK, PD and preliminary efficacy of multiple oral administrations of SNIPR001 when given concomitantly with SoC levofloxacin.

E Coli InfectionsAllogenic Transplant Patients

SNIPR Biome Aps.24 participantsStarted Feb 2025

Duarte, California, United States • San Francisco, California, United States • Baltimore, Maryland, United States +5 more locations

Active Not RecruitingPhase 3< 1 mile

Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome

NCT06050122

The aim of this clinical study is to find out how well Patidegib Gel 2% works in preventing new basal cell carcinomas (BCCs) developing on the face of adults with Gorlin syndrome, and how safe Patidegib Gel 2% is to use. People who take part will apply either Patidegib Gel 2% or a Vehicle Gel (with no active drug substance) to their face twice a day for a year (12 months). The number of new BCCs on the face will be compared between those who used Patidegib Gel 2% or Vehicle Gel after 12 months.

Gorlin Syndrome

Sol-Gel Technologies, Ltd.140 participantsStarted Mar 2024

Rogers, Arkansas, United States • Fremont, California, United States • Los Angeles, California, United States +37 more locations

Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant

Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome

Find Trials by Condition in New York

Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial

A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease

Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies

Intent of Surgery for IPMN

Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)

A Study of the MIND Diet for Persons With Multiple Sclerosis

Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants

A Study of CLE-100 (Oral Esketamine) in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO Study

Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) in Subjects With Dim Light Vision Disturbances

Neurodevelopment of Hypoglycemic Neonates

Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United States

A Study to Evaluate Efficacy and Safety of SAGE-547 in Participants With Severe Postpartum Depression (547-PPD-202B)

Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma

Remote Patient Monitoring for Chronic Hypertension During Pregnancy (REACH)

SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors

COVID-19 Study of Pharmacokinetics, Safety, Tolerability, and Efficacy of Intravenous Anti-Spike(s) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) for the Treatment of Pediatric Patients Hospitalized Due to COVID-19

I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW).

A Study of GSK5733584 in Combination With Anti-cancer Therapies for Advanced Solid Tumors